Sign In
to Vote &
Create Storyboards.
 
In anticipation of the March 13th deadline for comments on the FDA proposed rule on prescription generic drug labeling, today 21 health industry groups submitted a new letter to the FDA, raising concerns about the proposed regulation."Groups from every part of the healthcare supply chain agree that the Proposed Rule raises serious questions about patient safety, cost and access. That is why pharmacists, chain drug stores, distributors , pharmacy benefit managers, suppliers, healthcare advocacy g...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard